Outlook Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Outlook Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Outlook Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $19.3K.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $14.5K, a 47.6% decline from 2023.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $27.7K, a 40.7% decline from 2022.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $46.7K, a 70.6% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.5K -$13.2K -47.6% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-27
2023 $27.7K -$19K -40.7% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-27
2022 $46.7K -$112K -70.6% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-22
2021 $159K -$28.8K -15.4% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 $188K Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.